Related Experiment Video

Updated: Oct 7, 2025

Rapid Generation of Amyloid from Native Proteins In vitro
05:48

Rapid Generation of Amyloid from Native Proteins In vitro

Published on: December 5, 2013

6.3K

Molecular Mechanisms of Cardiac Amyloidosis

Yukihiro Saito1, Kazufumi Nakamura2, Hiroshi Ito2

  • 1Department of Cardiovascular Medicine, Okayama University Hospital, Okayama 700-8558, Japan.

International Journal of Molecular Sciences
|January 11, 2022
PubMed

Insights

Treatments for cardiac amyloidosis have improved, but methods to remove existing amyloid deposits are still needed. Further research is required to protect cardiovascular cells from amyloid cytotoxicity.

Area of Science:

  • Cardiology
  • Biochemistry
  • Molecular Biology

Background:

  • Cardiac amyloidosis significantly impacts patient prognosis.
  • Therapeutic advancements in transthyretin amyloidosis (ATTR) and light-chain amyloidosis (AL) have improved outcomes by targeting causative protein production.
  • Current treatments do not effectively remove existing amyloid deposits.

Purpose of the Study:

  • To review the molecular mechanisms of cardiac amyloidosis.
  • To discuss current and needed therapeutic strategies for cardiac amyloidosis.
  • To highlight the need for methods to reduce amyloid cytotoxicity.

Main Methods:

  • This is a review article, synthesizing existing research.
  • Literature search on molecular mechanisms and treatments of cardiac amyloidosis.
  • Analysis of therapeutic approaches for ATTR and AL amyloidosis.

Main Results:

  • Established treatments focus on reducing the production of amyloidogenic proteins.
  • A significant gap exists in methods for removing deposited amyloid fibrils.
  • Cytotoxicity from amyloid deposits and precursor proteins poses a threat to cardiovascular cells.

Conclusions:

  • While protein production suppression improves prognosis in cardiac amyloidosis, effective amyloid removal strategies are lacking.
  • Developing methods to reduce amyloid cytotoxicity is crucial for protecting the heart.
  • Further research into novel therapeutic targets and removal techniques is essential.
Keywords:
amyloidcytotoxicityimmunoglobulin light chaintransthyretin

More Related Videos

Interactions with and Membrane Permeabilization of Brain Mitochondria by Amyloid Fibrils15:04

Interactions with and Membrane Permeabilization of Brain Mitochondria by Amyloid Fibrils

Published on: September 28, 2019

6.1K
Flow Cytometry-Based Quantification and Analysis of Myocardial B-Cells12:46

Flow Cytometry-Based Quantification and Analysis of Myocardial B-Cells

Published on: August 17, 2022

2.7K

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
10.6K
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
113
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
56
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
85
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
85
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.0K